Cargando…
The Wnt non-canonical signaling modulates cabazitaxel sensitivity in prostate cancer cells
BACKGROUND: Despite new drugs, metastatic prostate cancer remains fatal. Growing interest in the latest approved cabazitaxel taxane drug has markedly increased due to the survival benefits conferred when used at an earlier stage of the disease, its promising new therapeutic combination and formulati...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266300/ https://www.ncbi.nlm.nih.gov/pubmed/32484838 http://dx.doi.org/10.1371/journal.pone.0234078 |